Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care

BACKGROUND: MP-AzeFlu (Dymista®; spray of azelastine/fluticasone propionate) is the most effective allergic rhinitis (AR) treatment available. Its effect on asthma outcomes in patients with AR and asthma is unknown. METHODS: This pre-post historical cohort study, using the Optimum Patient Care Resea...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:World Allergy Organ J
Main Authors: De Jong, Hilda J.I., Voorham, Jaco, Scadding, Glenis K., Bachert, Claus, Canonica, Giorgio Walter, Smith, Peter, Wahn, Ulrich, Ryan, Dermot, Castillo, Jose A., Carter, Victoria A., Murray, Ruth B., Price, David B.
Formato: Artigo
Idioma:Inglês
Publicado: World Allergy Organization 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753940/
https://ncbi.nlm.nih.gov/pubmed/33376573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2020.100490
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares